Loading provider…
Loading provider…
Dermatology Physician in Coral Gables, FL
NPI: 1144258724Primary Practice Location
Florida Academic Dermatology Centers LLC
475 Biltmore Way, Coral Gables, FL
Primary Employer
Dermatology Group of Florida, P.A.
dermgroup.net
HQ Phone
Get MD Francisco's Phone Numberphone_androidMobile
Get MD Francisco's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1987 - 2026

American Board of Dermatology
Dermatology

American Board of Dermatology
Dermatological Immunology/Diagnostic & Laboratory Immunology
Mass General Brigham/Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's Hosp
Residency • Dermatology
1981 - 1984
Guy's, King's and St Thomas' School of Medical Education
Medical School
Until 1979
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 278 | 405 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 246 | 416 |
| 3 | 17110Destruction of up to 14 skin growths | 203 | 263 |
| 4 | 17000Destruction of skin growth | 146 | 190 |
| 5 | 17003Destruction of 2-14 skin growths | 120 | 587 |
Apremilast and psoriasis in the real world: A retrospective case series.
Authors: Lauren Dozier
Publication Date: 2019-08-02
Reiter's Syndrome
Authors: Tobi B. Richman, Francisco A. Kerdel
Publication Date: 1988-07
Infliximab for hidradenitis suppurativa.
Authors: Anne Burdick, Robert Kirsner, Tory Sullivan
Publication Date: 2003-11
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Ixekizumab
Lead Sponsor: Coherus Oncology, Inc.
Collaborators: Shire
Intervention / Treatment: DRUG: CHS-0214, DRUG: Etanercept
Lead Sponsor: Florida Academic Dermatology Centers
Collaborators: Celgene Corporation
Intervention / Treatment: DRUG: Lenalidomide